vs
Coursera, Inc.（COUR）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
Orthofix Medical Inc.的季度营收约是Coursera, Inc.的1.1倍（$219.9M vs $196.9M），Orthofix Medical Inc.净利率更高（-1.0% vs -13.6%，领先12.6%），Coursera, Inc.同比增速更快（9.9% vs 2.0%），Orthofix Medical Inc.自由现金流更多（$16.8M vs $5.4M），过去两年Orthofix Medical Inc.的营收复合增速更高（8.0% vs 7.9%）
Coursera Inc.是美国营利性在线教育平台，由斯坦福大学计算机科学教授吴恩达与达芙妮·科勒于2012年创立。创立初期它作为全球大型开放式网络课程平台运营，目前和全球多所大学及各类机构合作，提供涵盖多个学科领域的在线课程、证书与学位项目。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
COUR vs OFIX — 直观对比
营收规模更大
OFIX
是对方的1.1倍
$196.9M
营收增速更快
COUR
高出7.9%
2.0%
净利率更高
OFIX
高出12.6%
-13.6%
自由现金流更多
OFIX
多$11.4M
$5.4M
两年增速更快
OFIX
近两年复合增速
7.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $196.9M | $219.9M |
| 净利润 | $-26.8M | $-2.2M |
| 毛利率 | 54.2% | 71.1% |
| 营业利润率 | -16.4% | 0.2% |
| 净利率 | -13.6% | -1.0% |
| 营收同比 | 9.9% | 2.0% |
| 净利润同比 | -24.1% | 92.4% |
| 每股收益（稀释后） | $-0.16 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收COUROFIX
| Q4 25 | $196.9M | $219.9M | ||
| Q3 25 | $194.2M | $205.6M | ||
| Q2 25 | $187.1M | $203.1M | ||
| Q1 25 | $179.3M | $193.6M | ||
| Q4 24 | $179.2M | $215.7M | ||
| Q3 24 | $176.1M | $196.6M | ||
| Q2 24 | $170.3M | $198.6M | ||
| Q1 24 | $169.1M | $188.6M |
净利润COUROFIX
| Q4 25 | $-26.8M | $-2.2M | ||
| Q3 25 | $-8.6M | $-22.8M | ||
| Q2 25 | $-7.8M | $-14.1M | ||
| Q1 25 | $-7.8M | $-53.1M | ||
| Q4 24 | $-21.6M | $-29.1M | ||
| Q3 24 | $-13.7M | $-27.4M | ||
| Q2 24 | $-22.9M | $-33.4M | ||
| Q1 24 | $-21.3M | $-36.0M |
毛利率COUROFIX
| Q4 25 | 54.2% | 71.1% | ||
| Q3 25 | 54.6% | 72.2% | ||
| Q2 25 | 54.9% | 68.7% | ||
| Q1 25 | 54.6% | 62.8% | ||
| Q4 24 | 53.3% | 69.0% | ||
| Q3 24 | 54.6% | 68.7% | ||
| Q2 24 | 53.0% | 67.8% | ||
| Q1 24 | 52.9% | 67.5% |
营业利润率COUROFIX
| Q4 25 | -16.4% | 0.2% | ||
| Q3 25 | -8.0% | -8.3% | ||
| Q2 25 | -8.1% | -7.9% | ||
| Q1 25 | -8.0% | -25.2% | ||
| Q4 24 | -17.0% | -5.3% | ||
| Q3 24 | -12.3% | -9.6% | ||
| Q2 24 | -18.3% | -12.5% | ||
| Q1 24 | -17.6% | -15.6% |
净利率COUROFIX
| Q4 25 | -13.6% | -1.0% | ||
| Q3 25 | -4.4% | -11.1% | ||
| Q2 25 | -4.2% | -6.9% | ||
| Q1 25 | -4.4% | -27.4% | ||
| Q4 24 | -12.1% | -13.5% | ||
| Q3 24 | -7.8% | -13.9% | ||
| Q2 24 | -13.4% | -16.8% | ||
| Q1 24 | -12.6% | -19.1% |
每股收益（稀释后）COUROFIX
| Q4 25 | $-0.16 | $-0.05 | ||
| Q3 25 | $-0.05 | $-0.57 | ||
| Q2 25 | $-0.05 | $-0.36 | ||
| Q1 25 | $-0.05 | $-1.35 | ||
| Q4 24 | $-0.13 | $-0.76 | ||
| Q3 24 | $-0.09 | $-0.71 | ||
| Q2 24 | $-0.15 | $-0.88 | ||
| Q1 24 | $-0.14 | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $792.6M | $82.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $635.7M | $450.0M |
| 总资产 | $1.0B | $850.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资COUROFIX
| Q4 25 | $792.6M | $82.0M | ||
| Q3 25 | $797.7M | $62.9M | ||
| Q2 25 | $775.1M | $65.6M | ||
| Q1 25 | $748.0M | $58.0M | ||
| Q4 24 | $726.1M | $83.2M | ||
| Q3 24 | $719.4M | $30.1M | ||
| Q2 24 | $708.8M | $26.4M | ||
| Q1 24 | $725.4M | $27.0M |
总债务COUROFIX
| Q4 25 | — | — | ||
| Q3 25 | — | $157.2M | ||
| Q2 25 | — | $157.0M | ||
| Q1 25 | — | $156.9M | ||
| Q4 24 | — | $157.0M | ||
| Q3 24 | — | $118.5M | ||
| Q2 24 | — | $118.0M | ||
| Q1 24 | — | $118.2M |
股东权益COUROFIX
| Q4 25 | $635.7M | $450.0M | ||
| Q3 25 | $639.5M | $442.5M | ||
| Q2 25 | $627.0M | $458.3M | ||
| Q1 25 | $610.5M | $458.3M | ||
| Q4 24 | $597.4M | $503.1M | ||
| Q3 24 | $593.3M | $525.9M | ||
| Q2 24 | $585.2M | $546.0M | ||
| Q1 24 | $609.1M | $570.3M |
总资产COUROFIX
| Q4 25 | $1.0B | $850.6M | ||
| Q3 25 | $995.3M | $832.6M | ||
| Q2 25 | $979.9M | $837.2M | ||
| Q1 25 | $951.2M | $823.1M | ||
| Q4 24 | $930.3M | $893.3M | ||
| Q3 24 | $914.1M | $867.9M | ||
| Q2 24 | $904.4M | $882.0M | ||
| Q1 24 | $916.3M | $906.0M |
负债/权益比COUROFIX
| Q4 25 | — | — | ||
| Q3 25 | — | 0.36× | ||
| Q2 25 | — | 0.34× | ||
| Q1 25 | — | 0.34× | ||
| Q4 24 | — | 0.31× | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.22× | ||
| Q1 24 | — | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $5.8M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $5.4M | $16.8M |
| 自由现金流率自由现金流/营收 | 2.7% | 7.6% |
| 资本支出强度资本支出/营收 | 0.2% | 4.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $107.2M | $-1.3M |
8季度趋势，按日历期对齐
经营现金流COUROFIX
| Q4 25 | $5.8M | $27.7M | ||
| Q3 25 | $33.9M | $12.4M | ||
| Q2 25 | $35.5M | $11.6M | ||
| Q1 25 | $33.5M | $-18.4M | ||
| Q4 24 | $19.2M | $23.7M | ||
| Q3 24 | $27.9M | $11.7M | ||
| Q2 24 | $23.8M | $9.0M | ||
| Q1 24 | $24.5M | $-18.6M |
自由现金流COUROFIX
| Q4 25 | $5.4M | $16.8M | ||
| Q3 25 | $33.7M | $2.5M | ||
| Q2 25 | $35.1M | $4.5M | ||
| Q1 25 | $33.0M | $-25.1M | ||
| Q4 24 | $18.1M | $15.2M | ||
| Q3 24 | $27.7M | $6.3M | ||
| Q2 24 | $23.6M | $-360.0K | ||
| Q1 24 | $24.4M | $-29.1M |
自由现金流率COUROFIX
| Q4 25 | 2.7% | 7.6% | ||
| Q3 25 | 17.4% | 1.2% | ||
| Q2 25 | 18.8% | 2.2% | ||
| Q1 25 | 18.4% | -13.0% | ||
| Q4 24 | 10.1% | 7.0% | ||
| Q3 24 | 15.7% | 3.2% | ||
| Q2 24 | 13.9% | -0.2% | ||
| Q1 24 | 14.4% | -15.4% |
资本支出强度COUROFIX
| Q4 25 | 0.2% | 4.9% | ||
| Q3 25 | 0.1% | 4.8% | ||
| Q2 25 | 0.2% | 3.5% | ||
| Q1 25 | 0.3% | 3.5% | ||
| Q4 24 | 0.6% | 4.0% | ||
| Q3 24 | 0.1% | 2.7% | ||
| Q2 24 | 0.1% | 4.7% | ||
| Q1 24 | 0.1% | 5.6% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
COUR
| Consumer Segment | $131.5M | 67% |
| Enterprise Segment | $65.4M | 33% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
